Treating Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Harry P. Erba, MD, PhD for a review of updates in the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN). This presentation discusses current approaches to the management of BPDCN along with a recent data release from the American Society of Hematology Meeting (ASH).

Program Content

Activities

  • BPDCN
    Treating Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 17, 2024

    Expires: July 30, 2024